tiprankstipranks
Trending News
More News >
Turnstone Biologics Corp. (TSBX)
:TSBX
US Market
Advertisement

Turnstone Biologics Corp. (TSBX) Price & Analysis

Compare
Followers

TSBX Stock Chart & Stats


Turnstone Biologics Corp. News

TSBX FAQ

What was Turnstone Biologics Corp.’s price range in the past 12 months?
Currently, no data Available
What is Turnstone Biologics Corp.’s market cap?
Currently, no data Available
When is Turnstone Biologics Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Turnstone Biologics Corp.’s earnings last quarter?
Currently, no data Available
Is Turnstone Biologics Corp. overvalued?
According to Wall Street analysts Turnstone Biologics Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Turnstone Biologics Corp. pay dividends?
    Turnstone Biologics Corp. does not currently pay dividends.
    What is Turnstone Biologics Corp.’s EPS estimate?
    Turnstone Biologics Corp.’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Turnstone Biologics Corp. have?
    Currently, no data Available
    What happened to Turnstone Biologics Corp.’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Turnstone Biologics Corp.?
    Currently, no hedge funds are holding shares in TSBX

    Company Description

    Turnstone Biologics Corp.

    Turnstone Biologics Corp. (TSBX) is a biotechnology company focused on developing innovative cancer immunotherapies. Operating in the biopharmaceutical sector, the company is dedicated to harnessing the power of the immune system to treat solid tumors through its proprietary viral immunotherapy platforms.

    Turnstone Biologics Corp. (TSBX) Earnings & Revenues

    Currently, no data available
    Please return soon. This page is being updated.
    Similar Stocks
    Company
    Price & Change
    Follow
    Carisma Therapeutics
    Cyclerion Therapeutics
    Aprea Therapeutics
    Dogwood Therapeutics
    HCW Biologics

    Ownership Overview

    2.80%96.95%
    Insiders
    2.80%
    Mutual Funds
    ― Other Institutional Investors
    96.95% Public Companies and
    Individual Investors

    Options Prices

    Currently, No data available
    ---
    Popular Stocks
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis